NO304176B1 - Antiallergisk sammensetning inneholdende cetirizin for oftalmisk eller nasal anvendelse - Google Patents

Antiallergisk sammensetning inneholdende cetirizin for oftalmisk eller nasal anvendelse

Info

Publication number
NO304176B1
NO304176B1 NO934630A NO934630A NO304176B1 NO 304176 B1 NO304176 B1 NO 304176B1 NO 934630 A NO934630 A NO 934630A NO 934630 A NO934630 A NO 934630A NO 304176 B1 NO304176 B1 NO 304176B1
Authority
NO
Norway
Prior art keywords
ophthalmic
antiallergic composition
composition containing
nasal use
containing cetirizine
Prior art date
Application number
NO934630A
Other languages
English (en)
Norwegian (no)
Other versions
NO934630L (no
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO934630L publication Critical patent/NO934630L/no
Publication of NO304176B1 publication Critical patent/NO304176B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO934630A 1992-12-25 1993-12-15 Antiallergisk sammensetning inneholdende cetirizin for oftalmisk eller nasal anvendelse NO304176B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
NO934630L NO934630L (no) 1994-06-27
NO304176B1 true NO304176B1 (no) 1998-11-09

Family

ID=18380671

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934630D NO934630D0 (no) 1992-12-25 1993-12-15 Antiallergisk sammensetning for oftalmisk eller masal anvendelse
NO934630A NO304176B1 (no) 1992-12-25 1993-12-15 Antiallergisk sammensetning inneholdende cetirizin for oftalmisk eller nasal anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO934630D NO934630D0 (no) 1992-12-25 1993-12-15 Antiallergisk sammensetning for oftalmisk eller masal anvendelse

Country Status (23)

Country Link
US (1) US5419898A (fr)
EP (1) EP0605203B1 (fr)
JP (1) JP3683595B2 (fr)
KR (1) KR100276743B1 (fr)
CN (1) CN1050514C (fr)
AT (1) ATE164068T1 (fr)
AU (1) AU666413B2 (fr)
BG (1) BG61101B1 (fr)
CA (1) CA2112014C (fr)
CZ (1) CZ283029B6 (fr)
DE (1) DE69317537T2 (fr)
DK (1) DK0605203T3 (fr)
ES (1) ES2115733T3 (fr)
FI (1) FI111805B (fr)
HU (2) HU218672B (fr)
LT (1) LT3344B (fr)
LV (1) LV10688B (fr)
NO (2) NO934630D0 (fr)
NZ (1) NZ250519A (fr)
PL (1) PL173347B1 (fr)
RU (1) RU2130774C1 (fr)
SK (1) SK279503B6 (fr)
TW (1) TW401300B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
EP1006969A1 (fr) * 1996-09-27 2000-06-14 Nastech Pharmaceutical Co. Formulations intranasales pour favoriser le sommeil et leur procede d'utilisation
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (fr) 1997-11-26 1999-06-02 Ucb, S.A. Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
WO2000012137A1 (fr) 1998-09-02 2000-03-09 Allergan Sales, Inc. Compositions contenant de la cyclodextrine et un agent conservateur
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
CN101632642B (zh) * 2002-01-15 2011-06-08 Ucb法奇姆股份有限公司 口感和稳定性改善的配方
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
WO2006011051A1 (fr) * 2004-07-22 2006-02-02 Pfizer Products Inc. Formulation de masquage du gout comprenant un medicament a dissolution retardee et/ou de la cyclodextrine a dissolution amelioree
PL1888548T3 (pl) 2005-05-26 2013-01-31 Neuron Systems Inc Pochodna chinoliny do leczenia schorzeń siatkówki
WO2006137433A1 (fr) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. Préparation aqueuse comprenant de la levocabastine solubilisée
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
CN103768070A (zh) * 2006-03-13 2014-05-07 株式会社·R-技术上野 水性组合物
WO2008025560A1 (fr) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Procédés servant à masquer le goût de compositions nébulisées pour thérapie par inhalation nasale et pulmonaire
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
PT2408453T (pt) * 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011017909A1 (fr) * 2009-08-12 2011-02-17 鲁南贝特制药有限公司 Solution pharmaceutique de chlorhydrate de cetirizine
EP2496593B1 (fr) 2009-11-06 2015-08-12 Yale University Compositions amphiphiles et procédés de préparation utilisant celles-ci
CA2782015C (fr) 2009-12-11 2020-08-25 Neuron Systems, Inc. Compositions ophthalmiques topiques et methodes de traitement de la degenerescence maculaire
US9492552B2 (en) * 2011-11-29 2016-11-15 Jurox Pty Ltd Injectable aqueous pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
BR112018003250A2 (pt) 2015-08-21 2018-09-25 Aldeyra Therapeutics Inc compostos deuterados e usos dos mesmos
MX2018010292A (es) 2016-02-28 2018-09-27 Aldeyra Therapeutics Inc Tratamiento de condiciones oculares alergicas con ciclodextrinas.
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
US11241426B2 (en) * 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
WO2018170476A1 (fr) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Composés polymorphes et leurs utilisations
CA3077362A1 (fr) 2017-10-10 2019-04-18 Aldeyra Therapeutics, Inc. Traitement de troubles inflammatoires
EP3740191B1 (fr) 2018-01-18 2021-04-28 Faes Farma, S.A. Compositions ophtalmiques comprenant de la bilastine, une bêta-cyclodextrine et au moins un agent gélifiant
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
JP7505786B2 (ja) 2018-09-25 2024-06-25 アルデイラ セラピューティクス， インコーポレイテッド ドライアイ疾患を処置するための製剤
WO2020198064A1 (fr) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Formulations ophtalmiques et leurs utilisations
EP3725298A1 (fr) * 2019-04-16 2020-10-21 Faes Farma, S.A. Compositions pharmaceutiques stables et préservées de bilastine
CA3137301A1 (fr) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Composes polymorphes et leurs utilisations
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
EP4149470A4 (fr) 2020-05-13 2024-04-24 Aldeyra Therapeutics, Inc. Formulations pharmaceutiques et leurs utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
SK147493A3 (en) 1994-07-06
NO934630D0 (no) 1993-12-15
HU211972A9 (en) 1996-01-29
FI111805B (fi) 2003-09-30
PL301588A1 (en) 1994-06-27
PL173347B1 (pl) 1998-02-27
BG98327A (bg) 1994-08-30
EP0605203A2 (fr) 1994-07-06
BG61101B1 (bg) 1996-11-29
LT3344B (en) 1995-07-25
CZ283693A3 (en) 1994-07-13
DE69317537D1 (de) 1998-04-23
SK279503B6 (sk) 1998-12-02
LV10688A (lv) 1995-06-20
CA2112014A1 (fr) 1994-06-26
ATE164068T1 (de) 1998-04-15
CN1050514C (zh) 2000-03-22
DK0605203T3 (da) 1998-12-07
EP0605203B1 (fr) 1998-03-18
NZ250519A (en) 1995-03-28
KR940013511A (ko) 1994-07-15
DE69317537T2 (de) 1998-07-09
CN1094614A (zh) 1994-11-09
JPH06239748A (ja) 1994-08-30
AU5259793A (en) 1994-07-07
FI935851A0 (fi) 1993-12-23
EP0605203A3 (fr) 1994-11-02
ES2115733T3 (es) 1998-07-01
NO934630L (no) 1994-06-27
CZ283029B6 (cs) 1997-12-17
TW401300B (en) 2000-08-11
LV10688B (en) 1995-10-20
JP3683595B2 (ja) 2005-08-17
US5419898A (en) 1995-05-30
CA2112014C (fr) 2004-11-02
HUT69385A (en) 1995-09-28
HU218672B (hu) 2000-10-28
LTIP1669A (en) 1994-10-25
HU9303746D0 (en) 1994-04-28
FI935851A (fi) 1994-06-26
AU666413B2 (en) 1996-02-08
KR100276743B1 (ko) 2001-01-15
RU2130774C1 (ru) 1999-05-27

Similar Documents

Publication Publication Date Title
NO304176B1 (no) Antiallergisk sammensetning inneholdende cetirizin for oftalmisk eller nasal anvendelse
RU93056633A (ru) Антиаллергическая композиция для лечения глаз или носа
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
ES2081914T3 (es) Composicion antimicrobiana.
ES2071227T3 (es) Composicion para gotas para los ojos.
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
EP0990648A4 (fr) Derives de 4-quinolinol et bactericides pour l'agriculture et l'horticulture contenant lesdits derives comme principe actif
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
EP0398084A3 (fr) Composés hétérocycliques substitués par nitro
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
IT1197081B (it) Composizione sterilizzante ad attivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso
EP1130018A4 (fr) Medicaments contre la dependance aux drogues
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
ES2015896B3 (es) Sal de una morfolina sustituida con acido fluoborico y agente para la proteccion de la madera.
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
NO163813C (no) Forbindelser inneholdende perfluoralkylgrupper og anvendelse derav som avskummingsmiddel for vandige polymerdispersjoner.
DE69813165D1 (de) Hautdepigmentierungsmittel
MY109202A (en) Isothiazole derivatives and processes for preparing the same as well as termite controlling agents comprising the same as active ingredient
EP0509098A4 (en) Ataractic
NO301648B1 (no) Vandig belegningsmiddel inneholdende som matteringsmiddel vannsvellbare polymerpartikler
AU5264593A (en) Imidazole derivatives